• Interview with Rod S Passman, MD. Director, Center for Arrhythmia Research

  • Apr 25 2023
  • Length: 26 mins
  • Podcast

Interview with Rod S Passman, MD. Director, Center for Arrhythmia Research

Listen for free

View show details

  • Summary

  • Rod S Passman, MD is interviewed by Happitech CEO and Founder Yosef Safi Harb

    Rod S Passman, MD is Director, Center for Arrhythmia Research and Jules J. Reingold Professor of Electrophysiology, Professor of Medicine (Cardiology) and Preventative Medicine

    An innovator for patients in Atrial Fibrillation, Dr. Passman is a highly regarded cardiac electrophysiologist and is an internationally recognized leader in cardiac monitoring and stroke prevention.

    Dr. Passman pioneered the use of implantable cardiac monitors to search for atrial fibrillation in stroke patients, a strategy now part of standard practice around the world. His current research focuses on implantable and wearable heart monitors to guide the use of anticoagulants in patients with atrial fibrillation.

    In this wide-ranging interview Dr Passman describes some of the benefits for patients of the emergence of consumer-style devices for remote patient monitoring. Dr. Passman also calls for more small-scale research studies, in partnership with the manufacturers of these devices, to evidence their ability to improve patient outcomes and save healthcare costs to encourage reimbursement by Payers.
    Show More Show Less
Show More Show Less

What listeners say about Interview with Rod S Passman, MD. Director, Center for Arrhythmia Research

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.